RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 11 analysts with an average price target of $23.11. This is a potential upside of $19.86 (611.08%) from yesterday's end of day stock price of $3.25.

Rocket Pharmaceuticals's activity chart (see below) currently has 75 price targets and 111 ratings on display. The stock rating distribution of RCKT is 87.04% BUY and 12.96% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.19% with an average time for these price targets to be met of 150.5 days.

Highest price target for RCKT is $11, Lowest price target is $2, average price target is $20.43.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 20-Aug-2025. First documented stock forecast 27-Nov-2018.

Currently out of the existing stock ratings of RCKT, 47 are a BUY (87.04%), 7 are a HOLD (12.96%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$7.84 (248.10%)

$11

27 days ago
(20-Aug-2025)

3/15 (20%)

$7.25 (193.33%)

140

Buy

$4

$0.84 (26.58%)

$19

1 months 22 days ago
(25-Jul-2025)

1/8 (12.5%)

$0.86 (27.39%)

145

Buy

$10

$6.84 (216.46%)

$11

1 months 22 days ago
(25-Jul-2025)

0/10 (0%)

$6.86 (218.47%)

Hold

$42

1 months 23 days ago
(24-Jul-2025)

0/18 (0%)

$39.67 (1702.58%)

Buy

$8

$4.84 (153.16%)

$44

3 months 19 days ago
(28-May-2025)

1/10 (10%)

$5.52 (222.58%)

374

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 150.5 days on average for the stock forecasts to be realized with a an average price target met ratio 19.19

Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?

ESTHER RAJAVELU

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu has 8 price targets and 3 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Joshua Schimmer with highest potential upside - $56.4

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Richard Law with lowest potential downside - -$1.16

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?